ADVERTISEMENT
Clarifi®
Clarifi Imaging System is the first non-contact, noninvasive microvascular assessment tool that uses a proprietary optical imaging technique—spatial frequency domain imaging (SFDI)—to measure tissue oxygenation and perfusion at the point-of-care in seconds. Clarifi quantifies and maps five hemoglobin biomarkers of oxygenation and perfusion. These biomarkers help clinicians identify problems, manage patients, and personalize treatment to reduce ulcers and amputations.
Modulim
Modulim
Modulim delivers transformative health technology solutions that empower clinicians across the continuum of care to improve patient outcomes. Clarifi®, powered by Spatial Frequency Domain Imaging (SFDI) technology, quantifies and maps tissue health at the point-of-care through non-contact rapid microvascular assessment. Modulim Cloud™ promotes timely, proactive data-driven decisions to reduce lower-limb complications by digitally connecting clinicians and healthcare systems. Modulim is based in Irvine, CA, with a team dedicated to delivering powerful healthcare solutions that elevate the standard of care for patients with diabetes, kidney disease, and peripheral vascular disease.
HbT1 and HbT2 parameters provide indication of hemoglobin concentration at different depths in tissue.
The Clarifi Imaging System is indicated for use to determine oxygenation levels in superficial tissue for patients with potential circulatory compromise.
